Page results
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Patient information for patients who have been recommended to use a Polymem® dressing on your skin that has broken down due to radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This page provides information about the multidisciplinary Huntington’s Disease Clinic, which is held twice a month at the NHNN.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This Huntington’s disease service page provides information on Advance Care Planning: it gives patients and their loved ones the opportunity to talk about and document their wishes, preferences and priorities as the disease progresses.
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
File results
-
FOI/2022/0273 - Proton therapy
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0283 - Enhanced disinfection methods to eliminate HAIs in theatres, clinical areas and wards
-
FOI/2022/0302 - Treatment with conditions for rheumatology/ dermatology
-
FOI/2022/0304 - Histopathology labs that run immunohistochemistry diagnostic testing
-
FOI/2022/0326 - Use of temporary, locum or bank staff for Junior Doctors - shifts and spend
-
FOI/2022/0329 - Overseas visitor charges for abortion healthcare
-
FOI/2022/0330 - Sleep and respiratory services